Close Menu

The US Government Accountability Office recently released its findings from a sting conducted on several companies that sell direct-to-consumer genetic tests, finding that the results of such tests are often "of little or no practical use." But, writes Emily Singer in MIT's Technology Review, the most "shocking" findings come from a series of undercover phone calls made to 15 of these companies by GAO workers.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News reports the US National Institutes of Health is investing in studies of the long-term effects of COVID-19.

The National Health Service is to offer Novartis's Zolgensma for spinal muscular atrophy later this year, according to the Guardian.

Taiwan is to launch a pilot program offering genetic testing to cancer patients, the Taipei Times reports.

In PLOS this week: loci linked to protection against tuberculosis, identification of loci associated with increased risk of squamous cell carcinoma of the aerodigestive tract, and more.